{
  "ticker": "SHP",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02959989",
  "id": "02959989",
  "pages": 7,
  "price_sensitive": true,
  "date": "20250619",
  "time": "0942",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250619/pdf/06kwytwnsr6pby.pdf",
  "summary": "### Capital Raising Announcement:  \n- **Structure**: Two-tranche Placement + 1-for-3 Non-Renounceable Rights Issue  \n- **Total Capital Raised**: Up to **A$3.11 million** (A$1.83m Placement + A$1.28m Rights Issue).  \n- **Issue Price**: **A$0.003/share** (4.3% discount to 15-day VWAP).  \n- **Options**: 1 free option (A$0.006 exercise, 2-year expiry) per 2 new shares issued.  \n\n#### Key Timetable:  \n- **Ex-Date (Rights Issue)**: 2 July 2025  \n- **Record Date**: 3 July 2025  \n- **Rights Issue Close**: 17 July 2025  \n- **Tranche 1 Placement Shares Trading Start**: 30 June 2025  \n- **General Meeting (Tranche 2 Approval)**: August 2025  \n\n#### Other Material Details:  \n- **Creditor Offset**: K-Utec to receive **A$457k in shares** for services owed.  \n- **Director Participation**: Committed to A$106k in Rights Issue, A$294k in Tranche 2 Placement.  \n- **Post-Raising Share Consolidation**: Proposed 1-for-15 consolidation (subject to shareholder approval).  \n- **R&D Tax Rebate**: Expected **A$400k\u2013500k** refund by Q4 2025.  \n\n**Valuation Impact**: Dilution from new shares/options; potential upside from dual-asset strategy and R&D rebate.  \n\n*Omitted: Director bios, operational strategy commentary, general risk disclosures.*",
  "usage": {
    "prompt_tokens": 4380,
    "completion_tokens": 363,
    "total_tokens": 4743,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-18T23:52:39.932736"
}